Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Hogrefe Publishing Group  (2)
  • 2010-2014  (2)
  • 2014  (2)
Type of Medium
Publisher
  • Hogrefe Publishing Group  (2)
Language
Years
  • 2010-2014  (2)
Year
  • 2014  (2)
  • 1
    Online Resource
    Online Resource
    Hogrefe Publishing Group ; 2014
    In:  Praxis Vol. 103, No. 24 ( 2014-11-01), p. 1447-1463
    In: Praxis, Hogrefe Publishing Group, Vol. 103, No. 24 ( 2014-11-01), p. 1447-1463
    Abstract: Cerebral cavernomatous malformations (CCM) are a subgroup of low-pressure cerebral vascular malformation. They have an estimated prevalence of 0,1–4% of the population and account for 8–15% of all cerebral vascular malformations. Depending on their size and localization (supratentorial or infratentorial, brain stem), CCM may present with focal bleedings with or without neurological deficits, as epileptic seizures, or are diagnosed incidentally by MRI performed for unspecific symptoms (e.g. headache, vertigo), especially in younger patients (mostly in 2nd or 3rd decade). The decision-making in patients with CCM can be classified into four categories: surgical or conservative treatment of symptomatic or incidental lesions. The decision regarding the optimal therapy in the individual patient must be made in the knowledge of the natural history (risk for bleeding or epilepsy) on the one hand, and the surgical possibilities (accessibility of the lesion) including their estimated outcome on the other hand. Therefore, careful patient selection and appropriate experience of the centre is warranted in the management of CCM.
    Type of Medium: Online Resource
    ISSN: 1661-8157 , 1661-8165
    Language: German
    Publisher: Hogrefe Publishing Group
    Publication Date: 2014
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Hogrefe Publishing Group ; 2014
    In:  Praxis Vol. 103, No. 23 ( 2014-11-01), p. 1385-1396
    In: Praxis, Hogrefe Publishing Group, Vol. 103, No. 23 ( 2014-11-01), p. 1385-1396
    Abstract: Low-grade gliomas (LGG) are brain tumors with a low or intermediate biological aggressiveness. According to histopathological features, they are further specified as grade I or II by WHO criteria. Diffuse astrocytomas, oligodendrogliomas, and mixed gliomas are the most common LGG. They mainly affect young patients in their 3rd to 5th decade and often manifest with epileptic seizures. A macroscopically complete or near-complete tumor resection that does not induce additional neurological deficits, is recommended as first line therapy in surgically accessible tumors, as a significant benefit for overall survival has been demonstrated. The indication for adjuvant chemo- or radiotherapy must be discussed interdisciplinary in each case. MGMT promotor methylation, LOH 1p/19q, as well as the status of somatic mutations within IDH1/2 gene constitute biomarkers that may predict response to adjuvant therapy and may correlate to overall survival. These and other biomarkers could be of benefit in future managing plans to offer patients with LGG an individually tailored, optimal treatment.
    Type of Medium: Online Resource
    ISSN: 1661-8157 , 1661-8165
    Language: German
    Publisher: Hogrefe Publishing Group
    Publication Date: 2014
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages